翰宇药业双执行总裁“内外互补” 开启发展全新篇章

Core Insights - Shenzhen Hanyu Pharmaceutical Co., Ltd. has appointed Tang Yangming and Shen Yaping as executive presidents to enhance management structure and achieve complementary advantages [1][2] Group 1: Management Changes - Tang Yangming has over 20 years of experience in peptide drug research and has been a senior vice president at Hanyu Pharmaceutical, ensuring effective execution of company strategies [1] - Shen Yaping brings extensive experience from his tenure at Hengrui Medicine, focusing on international market strategies and commercialization, which aligns with Hanyu Pharmaceutical's expansion into overseas markets [1][2] Group 2: Strategic Implications - The addition of Shen Yaping is expected to infuse Hanyu Pharmaceutical with innovative drug development strategies, particularly in peptide drugs, enhancing clinical progression and commercialization efforts [2] - Tang Yangming's promotion reflects the company's commitment to internal talent development, ensuring continuity in core technologies and stable operations [2]